FRONTEO,Inc. (2158)

Market cap
¥32B
P/E ratio
51.9x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
Period EndEffective tax rate (%) (Million JPY)YoY (%)
Mar 31, 2025-56.7+1552.76%
Mar 31, 2024-3.4-658.00%
Mar 31, 20230.6-96.62%
Mar 31, 202218.2+462.84%
Mar 31, 20213.2-6.44%
Mar 31, 20203.5-95.82%
Mar 31, 201982.9-68.18%
Mar 31, 2018260.5+661.85%
Mar 31, 201734.2-95.64%
Mar 31, 2016784.5+1879.75%
Mar 31, 201539.6
AI Chat